Regístrese
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

ANNALS OF HEPATOLOGY is an international open access journal published bimonthly and is funded by Medica Sur Clinical Foundation, Mexico City, Mexico. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin-American Association for the Study of the Liver (ALEH) and the Canadian Association for the Study of the Liver (CASL) and publishes original papers, concise reviews, letters to the Editor, invited editorials, opinions and viewpoints in the field of Hepatology.

ANNALS OF HEPATOLOGY'S main topics are alcoholic liver disease, viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, genetic liver diseases, autoimmune hepatitis, drug¿induced liver injury and biliary diseases. The journal's aim is to publish articles focused on basic, clinic care and translational research that seeks to prevent rather than treat the complications of endstage liver disease.

See more Open Access

Indexed in:

Scopus, Web of Science, Medline

See more

Follow us:

1.895 (2018)
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2017 2018

Impact Factor 2018
1.895
CiteScore 2018

CiteScore measures average citations received per document published. Read more

CiteScore 2018
1.55

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR
0.628

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP
0.638
See more
Hide
Issue
Vol. 18. Issue 6.
Pages 783-934 (November - December 2019)
Editorial
Opinions
Hepatocellular carcinoma, a unique tumor with a lack of biomarkers
Jose D. Debes, Enrique Carrera, Angelo Z. Mattos, Jhon E. Prieto, Andre Boonstra
Ann Hepatol. 2019;18:786-7
Open access
Yellow Fever
Marcelo Simão Ferreira
Ann Hepatol. 2019;18:788-9
Open access
Concise reviews
Can Prohibitin 1 be a Safeguard against liver disease?
Lei Xia, Yuling Liu, Sujun Zhang, Yurong Yang, Zhigang Zhou, Jian Tu
Ann Hepatol. 2019;18:790-5
Open access
Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
Guohong-Liu, Qingxi-Zhao, Hongyun-Wei
Ann Hepatol. 2019;18:796-803
Open access
Impact of psychosocial status on liver transplant process
Lucia Golfieri, Stefano Gitto, Ranka Vukotic, Pietro Andreone, Fabio Marra, Maria Cristina Morelli, Matteo Cescon, Silvana Grandi
Ann Hepatol. 2019;18:804-9
Open access
Obesity and liver cancer
Carlo Saitta, Teresa Pollicino, Giovanni Raimondo
Ann Hepatol. 2019;18:810-5
Open access
Original articles
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure
Érica Araújo Mendes, Denise Regina Bairros de Pilger, Ana Catharina de Seixas Santos Nastri, Fernanda de Mello Malta, Bruno dos Santos Pascoalino, Luiz Augusto Carneiro D’Albuquerque, Andrea Balan, Lucio Holanda Gondim de Freitas, Edison Luis Durigon, Flair José Carrilho, João Renato Rebello Pinho
Ann Hepatol. 2019;18:816-24
Open access
miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro
Zongqiang Hu, Li Li, Jianghua Ran, Guang Chu, Hongqiang Gao, Licheng Guo, Jiapeng Chen
Ann Hepatol. 2019;18:825-32
Open access
Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis
Ender Gunes Yegin, Salih S. Durusoy, Filiz Ture Ozdemir, Erdem F. Kombak, Cigdem Ataizi-Celikel, Osman C. Ozdogan
Ann Hepatol. 2019;18:833-40
Open access
Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis
Shelley S. Glaess, Rebecca L. Attridge, Rebecca L. Brady, Russell T. Attridge
Ann Hepatol. 2019;18:841-8
Open access
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil
Cirley Maria de Oliveira Lobato, Liana Codes, Giovanni Faria Silva, Aécio Flávio Meirelles Souza, Henrique Sérgio Moraes Coelho, Maria Lucia Alves Pedroso, Edison Roberto Parise, Leila Maria Soares Tojal de Barros Lima, Luiz Augusto Borba, Andreia Silva Evangelista, Rosamar Eulira Fontes Rezende, Hugo Cheinquer, Aline Satie Oba Kuniyoshi, Rodrigo Sebba Aires, Eloiza Helena Dias Quintela, Liliana Sampaio Costa Mendes, Fábio Carneiro Vosqui Nascimento, José Eymard Moraes de Medeiros Filho, Maria Lúcia Cardoso Gomes Ferraz, Edson Abdala, Paulo Lisboa Bittencourt,
Ann Hepatol. 2019;18:849-54
Open access
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis
Beatriz Castelló, Victoria Aguilera, M. Teresa Blázquez, Ángel Rubín, María García, Carmen Vinaixa, Salvador Benlloch, Fernando SanJuan, Eva Montalva, Rafael López, Marina Berenguer
Ann Hepatol. 2019;18:855-61
Open access
Infection in cirrhosis: A prospective study
Chandramouli Bhattacharya, Manisha Das-Mondal, Debkishore Gupta, Ajoy K. Sarkar, Sujit Kar-Purkayastha, Asokananda Konar
Ann Hepatol. 2019;18:862-8
Open access
Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4
Xiaolin Wei, Hui Liu, Xiaowu Li, Xiangde Liu
Ann Hepatol. 2019;18:869-78
Open access
Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis
Aurora Marina Loaeza-del Castillo, Alhely Gaytán-Santillán, Alma López-Tello, Merit Valdés-Almanza Merit, María del Pilar Milke-García, Jorge Flores-Rodríguez, Ulices Alvirde-García
Ann Hepatol. 2019;18:879-82
Open access
The regulatory role of microRNA-mRNA co-expression in hepatitis B virus-associated acute liver failure
Kanda Pan, Yunchao Wang, Ping Pan, Guanhua Xu, Lujiao Mo, Lijia Cao, Channi Wu, Xiaoyuan Shen
Ann Hepatol. 2019;18:883-92

  • HBV-associated ALF induced 43 DEmiRNAs and 523 DEGs.

  • Upregulated DEGs were associated with immune and inflammation responses.

  • Downregulated DEGs were related to metabolism and detoxication.

Open access
Associations between body mass index and mortality in acute-on-chronic liver failure patients
Ruimin Lai, Tianbin Chen, Zimu Wu, Su Lin, Yueyong Zhu
Ann Hepatol. 2019;18:893-7
Open access
Effect of laparoscopic splenectomy on portal vein thrombosis and serum YKL-40 in patients with cirrhotic portal hypertension
Ruizhao Qi, Xin Jin, Haida Shi, Chengfang Wang, Huixing Li, Xianjie Shi
Ann Hepatol. 2019;18:898-901
Open access
A simple scoring model for predicting early graft failure and postoperative mortality after liver transplantation
Rafael Diaz-Nieto, Panagis Lykoudis, Francis Robertson, Dinesh Sharma, Kevin Moore, Massimo Malago, Brian R. Davidson
Ann Hepatol. 2019;18:902-12
Open access
Alcohol and HBV synergistically promote hepatic steatosis
Zhan-Ming Li, Chao-Yue Kong, Shi-Long Zhang, Bing Han, Zheng-Yan Zhang, Li-Shun Wang
Ann Hepatol. 2019;18:913-7
Open access
The GLP-1 analog liraglutide attenuates acute liver injury in mice
Letícia Milani, Claudia M. Galindo, Natalia Mulinari Turin de Oliveira, Claudia Rita Corso, Eliana Rezende Adami, Maria Carolina Stipp, Olair Carlos Beltrame, Alexandra Acco
Ann Hepatol. 2019;18:918-28
Open access
Case report
Metastatic cholangiocarcinoma in a patient with undiagnosed Wilson disease
Marianna G. Mavilia, Aniket Sharma, Faripour Forouhar
Ann Hepatol. 2019;18:929-31
Open access
News
AMH Newsletter
Ann Hepatol. 2019;18:932
An acknowledgement
An Acknowledgement
Ann Hepatol. 2019;18:933-4
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.